Common Contracts
11 similar Executive Employment Agreement contracts by Monopar Therapeutics, Raptor Pharmaceutical Corp
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 9th, 2024 • Monopar Therapeutics • Pharmaceutical preparations • Illinois
This Executive Employment Agreement (the “Agreement”) is entered into as of May 23, 2024, by and between Karthik Radhakrishnan (“Executive”) and Monopar Therapeutics Inc. (the “Company”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 12th, 2021 • Monopar Therapeutics • Pharmaceutical preparations • Illinois
This Executive Employment Agreement (the “Agreement”) is entered into as of May 13, 2021, by and between Jose Octavio Pinto Costa Filho, MD (“Executive”) and Monopar Therapeutics Inc. (the “Company”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 12th, 2021 • Monopar Therapeutics • Pharmaceutical preparations • Illinois
This Executive Employment Agreement (the “Agreement”) is entered into as of May 11, 2021, by and between Andrew Cittadine (“Executive”) and Monopar Therapeutics Inc. (the “Company”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • September 13th, 2019 • Monopar Therapeutics • Pharmaceutical preparations • Illinois
This Amended and Restated Executive Employment Agreement (the “Agreement”) is entered into as of November 1, 2017, by and between Chandler D. Robinson (“Executive”) and Monopar Therapeutics Inc. (the “Company”) and replaces in its entirety the Executive Employment Agreement by and between Executive and the Company dated January 1, 2017.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • September 10th, 2019 • Monopar Therapeutics • Pharmaceutical preparations • Illinois
This Executive Employment Agreement (the “Agreement”) is entered into as of November 1, 2017, by and between Kim R. Tsuchimoto (“Executive”) and Monopar Therapeutics Inc. (the “Company”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 9th, 2017 • Monopar Therapeutics • Illinois
This Executive Employment Agreement (the “Agreement”) is entered into as of November 1, 2017, by and between Kim R. Tsuchimoto (“Executive”) and Monopar Therapeutics Inc. (the “Company”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 9th, 2017 • Monopar Therapeutics • Illinois
This Amended and Restated Executive Employment Agreement (the “Agreement”) is entered into as of November 1, 2017, by and between Chandler D. Robinson (“Executive”) and Monopar Therapeutics Inc. (the “Company”) and replaces in its entirety the Executive Employment Agreement by and between Executive and the Company dated January 1, 2017.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 5th, 2015 • Raptor Pharmaceutical Corp • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”) is entered into as of June 19, 2015, by and between Ashley Gould (“Executive”) and Raptor Pharmaceutical Corp. (the “Company”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 2nd, 2015 • Raptor Pharmaceutical Corp • Pharmaceutical preparations • California
This Amended and Restated Executive Employment Agreement (the “Agreement”) is entered into as of October 13, 2014, by and between David Happel (“Executive”) and Raptor Pharmaceutical Corp. (the “Company”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 2nd, 2015 • Raptor Pharmaceutical Corp • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”) is entered into as of January 2, 2015, by and between Krishna Polu, M.D. (“Executive”) and Raptor Pharmaceutical Corp. (the “Company”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 7th, 2015 • Raptor Pharmaceutical Corp • Pharmaceutical preparations • California
This Executive Employment Agreement (the “Agreement”) is entered into as of January 2, 2015, by and between Michael Smith (“Executive”) and Raptor Pharmaceutical Corp. (the “Company”).
